Abstract
Human embryonic stem cells (hESCs) are promising in regenerative medicine. Although several hESC-based clinical trials are under way, a widely accepted standard of clinical-grade cells remains obscure. To attain a completely xeno-free clinical-grade cell line, the system must be free of xenogenic components, the cells must have a comprehensive set of functions, and good manufacturing practice conditions must be used. In this study, following these criteria, we successfully derived two hESC lines, which were thereby considered "clinical-grade embryonic stem cells". In addition to the primary capacity for pluripotency, these two cell lines were efficiently differentiated into various types of clinical-grade progeny. Importantly, the cells were recognized by the National Institutes for Food and Drug Control of China for further eligible accreditation. These data indicate that we have established completely xeno-free clinical-grade hESC lines and their derivatives, which will be valuable for the foundation of an international standard for clinical-grade cells for therapy.
Citations
Jan 24, 2019·Protein & Cell·Lei WangJie Hao
Oct 12, 2019·Cell Death & Disease·Zhongwen LiJie Hao
Jun 20, 2018·Cell Death & Disease·Boya ZhangGuomin Zhou
Jul 22, 2018·Neural Regeneration Research·Chang-Geng SongHua Han
Sep 1, 2018·Cell Death & Disease·Xia LiJie Hao
Sep 25, 2018·Cell Discovery·Yong LiuZheng Qin Yin
Jun 18, 2020·Cell Research·Jun WuJie Hao
Oct 25, 2020·Biologicals : Journal of the International Association of Biological Standardization·Jiaqi Lu, Wei Wei
Oct 28, 2019·World Neurosurgery·Chengxian YangXinjie Bao
Dec 21, 2020·Stem Cell Research·Lei WangJie Hao
Feb 23, 2021·Cell Proliferation·Bowen ZhangYanhua Li
Mar 2, 2021·Frontiers in Cell and Developmental Biology·Yuxiao ZengHaiwei Xu
Oct 21, 2020·Experimental Eye Research·Qi-You LiZheng-Qin Yin
Jul 8, 2021·Cell Proliferation·Jing LiuBaoyang Hu
Aug 5, 2021·Cell Proliferation·Shi-Ying LiZheng-Qin Yin
Nov 2, 2021·Stem Cells Translational Medicine·Jiani CaoTongbiao Zhao